Novo Nordisk announced on Thursday that a key European Medicines Agency committee has backed a label update for weight-loss ...

But weight loss alone does not explain the drugs’ benefits. Both Holst and Sattar pointed to a discontinued GLP-1 drug once ...

Kidney disease results from kidney damage and subsequent decline in kidney function, says Dr. Pooja Budhiraja, a nephrologist ...

The European Medicines Agency (EMA) will allow Novo Nordisk to add risk reduction for events related to kidney disease to the ...

Explore the disproportionate burden of chronic kidney disease in the Black community and the need for empowerment and ...

Identifying the early signs of kidney stone disease is crucial for preventing complications and managing symptoms.

The EMA approved a kidney disease–related label expansion for the blockbuster GLP-1 drug after a study showed reduced risk of ...

Bangladesh is already struggling with a high rate of out-of-pocket health expenditure. The exorbitant cost of kidney dialysis ...

Our bodies have several vital organs that quietly toil away to keep us functioning properly. Among these are the kidneys, two fist-sized organs that sit on either side of the spine below the ribs.

Cleveland Clinic researchers have found definitive proof of a kidney microbiome that influences renal health and kidney stone ...